Aeris Environmental Ltd. announced the appointment of a new Independent Non-Executive Director to the Board of the Company, Dr. Jenny Harry. Dr. Harry has 20 years' experience in executive management of companies in the biotechnology, diagnostic and biopharmaceutical sectors. Jenny is an accomplished CEO with experience in growing companies from start-up to commercialisation, and has demonstrated expertise in building high-performing teams, establishing global partnerships, capital raising, investor relations, together with corporate governance and compliance. She is an experienced Non-Executive Director on the Boards of listed and unlisted companies. Dr Harry is currently a Non-Executive Director of Neuren Pharmaceuticals Limited and Ondek Pty Ltd, and a member of the Board's IP sub-Committee of the Children's Medical Research Institute.